Apologies to all as I re-read the PR and realized the timeline laid out by KB was for 5 years (2022) to get to 6%. That seems very achievable with a product with better performance and lower cost point.

The questions to be answered now are who is the partner and what will the J&J trial outcome provide in terms of cash to fund mfg expansion. The timeline has been set based on current status and now it's up to KB to execute to the plan.